Onco-Innovations Limited (CVE:ONCO) | Finanzwire

Basculer en Français

10472	Companies
220554	Keywords
149882	Articles
116640	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

BRIEF

published on 05/20/2026 at 00:05, 10 days 11 hours ago

Onco-Innovations Advances on ONC010 Development Program

Oncology Research Nanoparticle Formulation Manufacturing Optimization Clinical Translation ONC010 Development
PRESS RELEASE

published on 05/20/2026 at 00:00, 10 days 11 hours ago

Onco-Innovations Reports Continued Advancement of Key Materials Used in the Synthesis of its Active Pharmaceutical Ingredient for ONC010 Development Program
Onco-Innovations Limited reports progress in scale-up and development for ONC010 oncology program, focusing on A83 and B4 precursor components. Collaboration with Dalton Pharma Services aims at future GMP production

Oncology Scale-up Onco-Innovations Dalton Pharma Services ONC010
BRIEF

published on 05/16/2026 at 00:05, 14 days 11 hours ago

Onco-Innovations Advances Quality Testing for PNKP Inhibitor

Cancer Research Quality Standards Onco-Innovations Limited PNKP Inhibitor Validation Clinical Trials Preparation
PRESS RELEASE

published on 05/16/2026 at 00:00, 14 days 11 hours ago

Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Onco-Innovations advances CMC program by initiating analytical method validation for ONC010 API, partnering with Dalton Pharma Services for IND-enabling studies and Phase I clinical development support

IND-enabling Studies Onco-Innovations Dalton Pharma Services CMC Program Analytical Method Validation
BRIEF

published on 05/13/2026 at 00:05, 17 days 11 hours ago

Onco-Innovations Collaborates with AstraZeneca on AI in Oncology

Artificial Intelligence Research Collaboration Predictive Modeling AstraZeneca Partnership Oncology Outcomes
PRESS RELEASE

published on 05/13/2026 at 00:00, 17 days 11 hours ago

Onco-Innovations Announces Initiation of Research Collaboration within PROmAI
Onco-Innovations Limited announces collaboration with AstraZeneca for the PROmAI program to Predict Oncology Outcomes using Multimodal Artificial Intelligence in oncology research and development

AstraZeneca Multimodal AI Onco-Innovations Limited Oncology Outcomes PROmAI Program
BRIEF

published on 05/09/2026 at 00:05, 21 days 11 hours ago

Onco-Innovations Advances PNKP Inhibitor Development with Nucro-Technics' Bioanalysis

Onco-Innovations PNKP Inhibitor Nucro-Technics Bioanalysis LC-MS
PRESS RELEASE

published on 05/09/2026 at 00:00, 21 days 11 hours ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Onco-Innovations Limited announces Nucro-Technics Inc.'s advanced bioanalytical work on PNKP Inhibitor Technology, moving towards clinical evaluation

Onco-Innovations Limited PNKP Inhibitor Technology Nucro-Technics Inc. Bioanalytical Work Clinical Evaluation
BRIEF

published on 05/06/2026 at 00:05, 24 days 11 hours ago

Onco-Innovations and GSK Collaborate to Enhance Oncology Evidence

Clinical Trials Oncology GSK Real-world Data Onco-Innovations
PRESS RELEASE

published on 05/06/2026 at 00:00, 24 days 11 hours ago

Onco-Innovations Announces Inka Health Collaborative Research to Advance Oncology Evidence Generation
Onco-Innovations Limited's subsidiary Inka Health partners with GlaxoSmithKline for real-world data-driven oncology research collaboration. Project aims to enhance clinical trial findings transportability across diverse patient groups

Real-world Data Onco-Innovations Limited Inka Health GlaxoSmithKline Oncology Research Collaboration

Accesswire

Published on 05/30/2026 at 04:00, 7 hours 24 minutes ago

Vanta Announces Strategic Private Placement Financing to Advance U.S. Peptide Market Entry and Integrated Longevity and Consumer Health Sciences Platform
Published on 05/30/2026 at 02:40, 8 hours 44 minutes ago

BEACN Announces Financial Results for the First Quarter of 2026 and Update on Loan
Published on 05/30/2026 at 01:30, 9 hours 54 minutes ago

Core Critical Approved for Listing on OTCQB(R) Venture Market
Published on 05/30/2026 at 00:31, 10 hours 53 minutes ago

Gold Basin Resources Provides Updates on Arrangement with CANEX
Published on 05/29/2026 at 23:00, 12 hours 24 minutes ago

The Fresh Factory Reports Q1 2026 Financial Results with 17% Billed Revenue Growth, Completes New Facility Retrofit

View all ACCESSWIRE

EQS Group

Published on 05/29/2026 at 21:42, 13 hours 41 minutes ago

EQS-Adhoc: Consortium reaches definitive agreement to acquire 4finance Holding’s core consumer lending assets and launch Mellenu Holding
Published on 05/29/2026 at 21:30, 13 hours 54 minutes ago

Mutares portfolio company F.lli Ferrari Holding has signed an agreement for the partial sale of its Benelux operations to HMF Group
Published on 05/29/2026 at 20:00, 15 hours 24 minutes ago

Brödernas publishes quarterly report for Jan-Mar 2026
Published on 05/29/2026 at 19:46, 15 hours 37 minutes ago

CPI PROPERTY GROUP publishes financial results for the first quarter of 2026
Published on 05/29/2026 at 19:27, 15 hours 56 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/29/2026 at 22:00, 13 hours 24 minutes ago

Information on the Annual Financial Statements 2025
Published on 05/29/2026 at 18:00, 17 hours 24 minutes ago

Recticel Group acquires Isopanel NV to deliver integrated solutions in the cold storage panels market
Published on 05/29/2026 at 17:52, 17 hours 31 minutes ago

Share buyback mandate
Published on 05/29/2026 at 12:00, 23 hours 24 minutes ago

Capital increase through exercise of subscription rights
Published on 05/29/2026 at 10:30, 1 day ago

bioMérieux invests in France with a new facility to produce innovative diagnostics for the European market

View all LES ECHOS COMFI WIRE